Seymour Liebman
CIK: 0001252287
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
Seymour Liebman files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 1 reported Form 4/5 transaction by Seymour Liebman since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About LIEBMAN SEYMOUR
LIEBMAN SEYMOUR (SEC CIK 0001252287) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by LIEBMAN SEYMOUR, a Form 4, filed on Jan 2, 2025. Those filings report 1 transaction, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on LIEBMAN SEYMOUR's filings is in LEXINGTON, MA.
Recent filings by LIEBMAN SEYMOUR
- Nov 4, 2024: Grant or award of TTOO derivative securities (Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director
- Toft Robin, Director